12:00 AM
Jul 10, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Results

INS-1: Phase II

INSM said its 20-patient U.S. and Venezuelan randomized, placebo-controlled study showed that INS-1 enhanced ovulation, lowered systolic and diastolic blood pressure and improved lipid profiles in lean...

Read the full 114 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >